Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Adorjan

Immanuel Adorjan, Tulln AT

Patent application numberDescriptionPublished
20110003808OCTAHYDROQUINOLIZINES FOR ANTIDIABETIC TREATMENT - This invention relates to novel octahydroquinolizines for treatment or prevention of diabetes mellitus and its complications, for treatment or prevention of hyperlipidemia, for treatment of diabetic dyslipidemia, for treatment or prevention of the metabolic syndrome, for treatment of diseases related to metabolic dysfunction, for treatment of obesity or obesity-related diseases. The invention also includes pharmaceutical compositions and kits comprising these compounds alone or in combination with other drugs or compounds aiming towards an improved treatment or prevention of the aforementioned diseases or syndromes in humans or animals.01-06-2011
20110160238OCTAHYDROQUINOLIZINES FOR ANTIDIABETIC TREATMENT - This invention relates to octahydroquinolizines for pharmaceutical use with the following formula: (I), X=H, F; R=Methyl, Ethyl, nPropyl, nButyl.06-30-2011

John Adorjan, Highland Park, IL US

Patent application numberDescriptionPublished
20080289530Airborne device such as model rocket with light and sound for observing and retrieving - An airborne device such as a model rocket or balloon is provided with a light source and/or a sound source that makes the rocket visible during ascent, descent and recovery at night. The sound source is provided to assist in day time recovery. The light source may be located in a transparent or translucent nose cone section of a rocket or otherwise attached adjacent or in a balloon to assist in operation and viewing. The light source may include a timing or flashing feature to make the airborne device or rocket more visibly distinct during flight and recovery. Additional signaling and informational light sources may be added to other parts of the rocket and to the ground mounted launch apparatus to announce launching and/or improve the night time viewing. One form of the rocket system uses a count down feature with lights on the launch structure to signal when blast off will occur.11-27-2008

Matthew Adorjan, Waukegan, IL US

Patent application numberDescriptionPublished
20080289530Airborne device such as model rocket with light and sound for observing and retrieving - An airborne device such as a model rocket or balloon is provided with a light source and/or a sound source that makes the rocket visible during ascent, descent and recovery at night. The sound source is provided to assist in day time recovery. The light source may be located in a transparent or translucent nose cone section of a rocket or otherwise attached adjacent or in a balloon to assist in operation and viewing. The light source may include a timing or flashing feature to make the airborne device or rocket more visibly distinct during flight and recovery. Additional signaling and informational light sources may be added to other parts of the rocket and to the ground mounted launch apparatus to announce launching and/or improve the night time viewing. One form of the rocket system uses a count down feature with lights on the launch structure to signal when blast off will occur.11-27-2008

Peter Adorjan, Berlin DE

Patent application numberDescriptionPublished
20080254447Method and Nucleic Acids for the Improved Treatment of Breast Cell Proliferative Disorders - The present invention relates to modified and genomic sequences, to oligonucleotides and/or PNA-oligomers for detecting the cytosine methylation state of genomic DNA, as well as to a method for predicting the disease free survival and/or response of a subject with a cell proliferative disorder of the breast tissues, to endocrine treatment.10-16-2008
20110046005METHOD AND NUCLEIC ACIDS FOR THE ANALYSIS OF COLON CELL PROLIFERATIVE DISORDERS - Provided are methods and nucleic acids for detecting, differentiating or distinguishing between colon cell proliferative disorders by analysis of one or more of the genes Versican, TPEF, H-Cadherin, Calcitonin, and EYA4. Further provided are novel nucleic acid sequences useful for the cell proliferative disorder specific analysis of said genes as well as methods, assays and kits thereof.02-24-2011

Patent applications by Peter Adorjan, Berlin DE